Daniel J. DeAngelo, MD, PhD, Dana-Farber Cancer Institute

Articles

Well-Differentiated Systemic Mastocytosis vs Chronic Mast Cell Leukemia

September 20th 2021

The panel of experts discuss the clinical differences between well-differentiated systemic mastocytosis and chronic mast cell leukemia.

Case 4: Treatment and Management Considerations in MCL

September 13th 2021

The panel of experts in SM discuss the diagnosis and treatment of a 68-year-old female with mast cell leukemia.

Case 3: Indolent Systemic Mastocytosis

September 7th 2021

Dan DeAngelo, MD, PhD, presents the case of a patient with indolent systemic mastocytosis and urticaria pigmentosa.

Avapritinib: Approval and Clinical Practice Implications

September 7th 2021

A panel of experts share their reactions to the approval of avapritinib and discuss the clinical implications.

PATHFINDER Trial Efficacy Data

August 30th 2021

Dan DeAngelo, MD, PhD, reviews key efficacy data from the phase II PATHFINDER study.

Case 2: SM Treatment Algorithm and Supportive Care Recommendations

August 30th 2021

Patricia Lugar, MD, MS, shares an allergist’s perspective regarding treatment algorithms and supportive care recommendations for patients with systemic mastocytosis.

Case 2: Treatment and Management Considerations for SM

August 23rd 2021

The panel of experts in SM discuss the diagnosis and management of a 46-year-old woman with systemic mastocytosis.

Case 2: 46-year-old Woman With SM

August 23rd 2021

Dan DeAngelo, MD, PhD, presents the case of a 46-year-old woman with systemic mastocytosis and associated gastrointestinal symptoms.

Case 1: Treatment Algorithm and Supportive Care Recommendations

August 16th 2021

Patricia Lugar, MD, MS, shares treatment algorithm and supportive care recommendations for a 75-year-old man with systemic mastocytosis.

Case 1: Treatment and Management Considerations

August 16th 2021

The panel of experts in SM discuss the diagnosis and management of a 75-year-old man with systemic mastocytosis.

Case 1: 75-Year-Old Man With SM

August 9th 2021

Dan DeAngelo, MD, PhD, presents the case of a 75-year-old man with systemic mastocytosis and reviews WHO diagnostic criteria.

Considerations in SM: Hereditary Alpha Tryptasemia

August 9th 2021

Prithviraj Bose, MD, and Patricia Lugar, MD, MS, discuss the considerations and testing options for hereditary alpha tryptasemia in patients with systemic mastocytosis.

Considerations in Mast Cell Disorders

August 2nd 2021

The panel of experts highlights the importance of assessing symptomology and clinical characteristics in mast cell disorders.

Systemic Mastocytosis: Epidemiology and Diagnostic Criteria

August 2nd 2021

Experts in the field of mast cell disorders discuss the epidemiology and diagnostic criteria of systemic mastocytosis.